Adenovirus (Negative Control Serum)

  • Applications
    • IF
  • Code # ADN-3110
  • Size 0.5 mL
  • Price Call for Price
Specifications
  • Application:
    IF
  • Components:

    Adenovirus Negative Control Serum

  • Description:

    Vial containing 0.5 mL Adenovirus negative human control serum with protein stabilizer and 0.005% thimerosal. Stable at 2-8°C until labeled expiration date. IgM negative controls do not have to be pretreated to remove IgG. The control is intended to be used undiluted as provided. The staining reaction should exhibit less than 1+ fluorescence.

    INTENDED USE

    MBL Bion REAGENTS FOR IFA (Indirect Fluorescent Antibody) TESTS may be used in assays for the qualitative and/or semi-quantitative determination of specific IgG or IgM antibodies in human serum. The MBL Bion REAGENTS FOR IFA TESTS are intended for use as an aid in diagnosis of certain autoimmune diseases or for primary or active infection and/or as a determination of immunological experience with specific microorganisms.

  • Product Type:
    Control Serum
  • Research Area:
    Infectious Disease
  • Size:
    0.5 mL
References
  1. Laboratory Diagnosis of Viral Infections, Lennette, E.H. (ed), Dekker, New York, 1985.
  2. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, SixthEdition, Schmidt, N.J. and R.W. Emmons (Eds.), A.P.H.A., Washington, D.C., 1989.
  3. Weller, T.H., A.H. Coons, Fluorescent Antibody Studies with Agents of Varicella and Herpes Zoster Propagated In Vitro, Proc. Soc. Exp. Biol. Med., 86:789-794, 1954.
  4. Riggs, J.L., R.J. Siewald, J.H. Burckhalter, C.M. Downs, T.G. Metcalf, Isothiocyanate Compounds as Fluorescent Labeling Agents for Immune Serum, Am. J. Pathol. 34:1081-1097, 1958.
  5. Goldman, M.: Fluorescent Antibody Methods. New York, Academic Press, 1968.
  6. Kawamura, A. Jr.: Fluorescent Antibody Techniques and Their Application. Baltimore, University Park Press, 1969.
  7. Nairn, R.C.: Fluorescent Protein Tracing, Baltimore, Williams and Wilkins, 3rd Ed., 1969.
  8. Johnson, R.B., and R. Libby, Separation of Immunoglobulin M (IgM) Essentially Free of IgG From Serum in Systems Requiring Assay of IgM-Type Antibodies Without Interference From Rheumatoid Factor, J. Clin. Micro. 12:451-454, 1980.
  9. Gispen, R., J. Nagel, B. Brand-Saathof, S. DeGraff, Immunofluorescence Test for IgM Rubella Antibodies in Whole Serum After Absorption with Specific Anti-gamma Fc, Clin. Exp. Immunol., 22:431-437, 1975.
  10. Joassin, L., M. Reginster, Elimination of Nonspecific Cytomegalovirus Immunoglobulin M Activities in the Enzyme-Linked Immunosorbent Assay by Using Antihuman Immunoglobulin G, J. Clin. Microbiol. 23:576-581, 1986.
  11. Lyerla, H.C., F.T. Forrester, The Immunofluorescence (IF) Test, in: Immunofluorescence Methods in Virology, USDHHS, Georgia, 71-81, 1979.
  12. Keller, R., R. Psitchel, J.N. Goldman et al., An IgG-Fc Receptor Induced in Cytomegalovirus-Infected Human Fibroblasts, J. Immuno., 116:772-777, 1976.
  13. Westmoreland, D., J.F. Watkins, The IgG Receptor Induced by Herpes Simplex Virus: Studies Using Radioiodinated IgG, J. Gen. Virol., 24:167-178, 1974.
  14. Holborow, E.J., D.M. Weir, G.D. Johnson, A Serum Factor in Lupus Erythematosus With Affinity for Tissue Nuclei, Br. Med. J., 11:732-734, 1957.
  15. Berg, P.A., I. Roitt, D. Doniach, H.M. Cooper, Mitochondrial Antibodies in Primary Biliary Cirrhosis, Immunol. 17:281-293, 1969.
  16. Chernesky, M.A., C.G. Ray, T.F. Smith, Laboratory Diagnosis of Viral Infections, Cumitech 15, ASM, Washington, D.C., March 1982.
  17. Schmidt, N.J., Update on Class-specific Viral Antibody Assays, Clinical Immunology Newsletter, 5: 81-85, June, 1984.18.
  18. Gardner, P.S., J. McQuillin, Rapid Virus Diagnosis: Application of Immunofluorescence, In: Detection of Virus Specific IgM by Immunofluorescence, Butterworth, Boston, 259-287, 1980.
  19. Data on file, MBL Bion, Des Plaines, IL.